Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Immunitybio Inc IBRX

Immunitybio, Inc. is a vertically integrated, clinical-stage biotechnology company developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Using its proprietary platforms that amplify both the innate and adaptive branches of the immune system, its advances therapies and vaccines to defeat urologic and other cancers, as well as... see more

Recent & Breaking News (NDAQ:IBRX)

SHAREHOLDER ALERT: WeissLaw LLP Reminds WTRE, TNAV, RNET and NK Shareholders About Its Ongoing Investigations

PR Newswire January 12, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CHNG, BPFH, RP, MDCA, NK; Shareholders Are Encouraged to Contact the Firm

PR Newswire January 7, 2021

NantKwest Executive Chairman Dr. Patrick Soon-Shiong to Present at 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021

Business Wire January 6, 2021

WeissLaw LLP Reminds RNET, NK, HMSY, and QEP Shareholders About Its Ongoing Investigations

PR Newswire January 5, 2021

NANTKWEST ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of NK and Encourages Investors to Contact the Firm

GlobeNewswire January 5, 2021

MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages NK, PRGX, CBLI, and IPHI Shareholders to Contact the Firm

ACCESSWIRE IA January 2, 2021

STOCKHOLDER ALERT: Monteverde & Associates Launches Legal Investigation for the Following Transaction

ACCESSWIRE IA December 30, 2020

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers - WTRE, ARA, RESI, NK

GlobeNewswire December 30, 2020

WeissLaw LLP Reminds RNET, NK, HMSY, and QEP Shareholders About Its Ongoing Investigations

PR Newswire December 29, 2020

NANTKWEST INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of NantKwest, Inc. - NK

Business Wire December 29, 2020

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - PRGX, STND, NK, EIDX, ARA

PR Newswire December 28, 2020

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of NantKwest, Inc. (NK) and Encourages Shareholders to Contact the Firm

GlobeNewswire December 28, 2020

NANTKWEST (NK) SHAREHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of NantKwest, Inc.

GlobeNewswire December 28, 2020

NantKwest Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of NantKwest, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - NK

Business Wire December 24, 2020

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of NantKwest, Inc. - NK

PR Newswire December 23, 2020

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of NantKwest, Inc. Merger

GlobeNewswire December 23, 2020

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of NantKwest, Inc. - NK

GlobeNewswire December 22, 2020

SHAREHOLDER ALERT: WeissLaw LLP Investigates NantKwest, Inc.

PR Newswire December 21, 2020

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of NantKwest, Inc. (Nasdaq - NK)

ACCESSWIRE IA December 21, 2020

ImmunityBio and NantKwest to Merge, Creating a Leading Immunotherapy and Cell Therapy Company

Business Wire December 21, 2020